New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2014
09:40 EDTEXELSummer Street's chief scientific officer holds analyst/industry conference call
Chief Science Officer Classen discusses Exelixis' Cabozantinib for treatment of mestastatic prostate cancer on an Analyst/Industry conference call to be held on March 20 at 10 am.
News For EXEL From The Last 14 Days
Check below for free stories on EXEL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for EXEL

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use